Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jesse Treu Insider Profile
4 Followers
Jesse Treu, Director, Ten Percent Owner at Tobira Therapeutics, holds 1.89M shares in Aldeyra Therapeutics (Ticker: ALDX), holds 1.23M shares in Veracyte (Ticker: VCYT), holds 32.09K shares in Tobira Therapeutics (Ticker: TBRA). Most recently, Jesse Treu Sold ― shares of Aldeyra Therapeutics on Mar 28, 2019 for an estimated value of 968.40K.
Jesse Treu Tobira Therapeutics (TBRA)Director, Ten Percent Owner
Tobira Therapeutics (TBRA)
Director, Ten Percent Owner
Ranked #66,106 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-11.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jesse Treu holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 28, 2019 - Mar 28, 2020
Return:+72.60%
The most profitable trade made by Jesse Treu
Jesse Treu's Trading History
Tobira Therapeutics
Aug 28, 2013
―
Uninformative Buy
―
$1.35M
Veracyte
Mar 04, 2019
Director
Informative Sell
21.43M
$24.86M
Tandem Diabetes Care
―
Director, Ten Percent Owner
―
$0.00
Aldeyra Therapeutics
Mar 28, 2019
Director
Informative Sell
968.40K
$7.92M
CoLucid Pharmaceuticals
―
―
―
$0.00
Ocera Therapeutics
Jul 15, 2013
―
Informative Buy
7.99M
$6.31M
Clovis Oncology
Nov 21, 2011
―
Uninformative Buy
―
$765.20
Celator Pharmaceuticals
Jan 14, 2013
―
Informative Buy
―
$67.88M
Zogenix
Sep 20, 2011
―
Informative Buy
7.00M
$4.52M
Achillion Pharmaceuticals
Jan 18, 2013
―
Uninformative Buy
―
$1.65M
Esperion
Jul 02, 2013
Ten Percent Owner
Uninformative Buy
―
$71.92K
NuVasive
―
―
―
$318.00K
Senomyx
―
―
―
$91.18K
Vanda
―
Ten Percent Owner
―
$100.49K
Achaogen
Mar 17, 2014
―
Uninformative Buy
―
$847.25
Dicerna Pharma
Feb 04, 2014
―
Uninformative Buy
296.76K
$497.01K
Orexigen
Dec 22, 2011
―
Informative Buy
680.26K
$253.22
Alimera
Jun 03, 2011
Ten Percent Owner
Uninformative Buy
―
$141.13K
Evoke Pharma
Sep 30, 2013
Ten Percent Owner
Uninformative Buy
―
$11.64K
Cadence Pharma
Mar 21, 2014
―
Uninformative Sell
146.20M
―
Santarus
―
―
―
―
Somaxon Pharmaceuticals
―
―
―
―
Paratek Pharmaceuticals
Jan 30, 2009
―
Informative Sell
238.75K
$151.36K
Volcano Corp
―
―
―
―
Durata
Jul 24, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Jesse Treu's performance on stock
You May Also Like
Jesse Treu insider profile FAQ
What is the percentage of profitable transactions made by Jesse Treu?
The percentage of profitable transactions made by Jesse Treu is 50%.
What is the average return per transaction made by Jesse Treu?
The average return per transaction made by Jesse Treu is -11.10%.
What stocks does Jesse Treu hold?
Jesse Treu holds: TBRA, VCYT, TNDM, ALDX, CLCD, OCRX, CLVSQ, CLPM, ZGNX, ~ACHN, ESPR, NUVA, SNMX, VNDA, AKAOQ, DRNA, OREXQ, ALIM, EVOK, CADX, SNTS, SOMX, PRTK, VOLC, DRTX stocks.
What was Jesse Treu’s latest transaction?
Jesse Treu latest transaction was an Informative Sell of $968.40K.
What was Jesse Treu's most profitable transaction?
Jesse Treu’s most profitable transaction was an Informative Sell of ALDX stock on March 28, 2019. The return on the trade was 72.60%.
What is Jesse Treu's role in Tobira Therapeutics?
Jesse Treu's role in Tobira Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.